These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27960214)

  • 1. Principles of Antibiotic Management of Community-Acquired Pneumonia.
    Bender MT; Niederman MS
    Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM
    J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Resistance in Community-Acquired Pneumonia Pathogens.
    Wunderink RG; Yin Y
    Semin Respir Crit Care Med; 2016 Dec; 37(6):829-838. PubMed ID: 27960207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.
    Galli L; Montagnani C; Chiappini E; de Martino M
    Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
    Falcó V; Burgos J; Almirante B
    Expert Opin Pharmacother; 2018 Sep; 19(13):1503-1509. PubMed ID: 30198789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?
    Wunderink RG
    Infect Dis Clin North Am; 2013 Mar; 27(1):177-88. PubMed ID: 23398873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International survey of paediatric infectious diseases consultants on the management of community-acquired pneumonia complicated by pleural empyema.
    Osowicki J; Steer AC
    J Paediatr Child Health; 2019 Jan; 55(1):66-73. PubMed ID: 30051535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Weiss K; Tillotson GS
    Chest; 2005 Aug; 128(2):940-6. PubMed ID: 16100190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of community-acquired pneumonia in hospitalised patients.
    Mulazimoglu L
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S63-70. PubMed ID: 11574198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed?
    Cunha BA
    Chest; 2004 May; 125(5):1913-9. PubMed ID: 15136407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for community-acquired pneumonia in the elderly.
    Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
    Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving outcomes in community-acquired pneumonia.
    Bender MT; Niederman MS
    Curr Opin Pulm Med; 2016 May; 22(3):235-42. PubMed ID: 26859379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.